Other Consolidated Financial Statement Detail (Tables)

9 Months Ended

Sep. 30, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Other income (expense), net

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In millions)	2012			2011			2012			2011
Interest income	$	5.9		$	5.3		$	22.6		$	13.3
Interest expense	(8.7		)	(7.9		)	(23.1		)	(25.5		)
Impairments of investments	(3.5		)	(0.8		)	(4.8		)	(7.6		)
Gain (loss) on investments, net	1.3			(0.1		)	15.6			15.4
Foreign exchange gains (losses), net	0.1			(4.8		)	0.2			(5.8		)
Other, net	0.4			0.6			3.1			0.7
Total other income (expense), net	$	(4.5	)	$	(7.7	)	$	13.5		$	(9.5	)

Accrued Expenses and Other

(In millions)	As of September 30, 2012		As of December 31, 2011
Employee compensation and benefits	$	198.7	$	176.3
Revenue-related rebates	160.2		115.0
Deferred revenue	140.6		69.6
Collaboration expenses	46.6		44.2
Clinical development expenses	52.9		40.8
Royalties and licensing fees	45.3		47.4
Current portion of contingent consideration obligations	21.3		10.8
Other	200.6		173.1
Total accrued expenses and other	$	866.2	$	677.2